
Yahoo! News Search Results for psychopharmacology
Updated: 36 min 24 sec ago
September 7, 2008 - 04:41
The herb stevia is best known as a sweetener. Its active ingredients are known as steviosides.
September 5, 2008 - 19:47
Several factors come in the way of a dependable and conclusive outcome: panel
September 3, 2008 - 02:12
New research illuminates the benefits and risks of antipsychotic medication in children and its impact on individual well-being, social, educational and/or vocational functioning, and disease burden. Scientists have pointed out the challenges that clinicians encounter in treating children and adolescents with psychiatric disorders, and discuss the requirements for starting antipsychotic ...
September 2, 2008 - 16:21
Background Many of the psychiatric disorders observed in adults have their onset in childhood or adolescence. In fact some studies show that at least 20% of children and adolescents will fulfil a diagnostic criterion for a mental disorder before reaching adulthood.
September 1, 2008 - 15:26
( European College of Neuropsychopharmacology ) At the 21st Congress of the ECNP 2008 in Barcelona, Dr. Celso Arango, a renowned Spanish psychiatrist, will present the latest results from his research group on the benefits and risks of antipsychotic medication in children and its impact on individual well-being, social, educational and/or vocational functioning, and disease burden. Furthermore, ...
August 28, 2008 - 07:01
CME Outfitters announces an upcoming neuroscienceCME activity titled "Depression as a Mind-Body Disorder in Minority Populations:
August 27, 2008 - 17:09
U.S. scientists say they have created a synthetic molecule that could be used to treat chronic pain in patients with diseases such as diabetes or shingles.Northeastern University Professor Alexandros Makriyannis, Associate Professor Torjjorn Jarbe and former University of Connecticut researchers Chen Li and Qian Liu said their new molecule, AM1346, mimics, but is more powerful than, anandamide, ...
August 27, 2008 - 16:37
BOSTON, Aug. 27 (UPI) -- U.S. scientists say they have created a synthetic molecule that could be used to treat chronic pain in patients with diseases such as diabetes or shingles.
August 25, 2008 - 12:25
PsychoGenics Inc., announces the appointment of John McCall, Ph.D., as a member of its Scientific Advisory Board, reflecting the company's growth in the areas of Drug Discovery and Development.
August 25, 2008 - 12:00
TARRYTOWN, N.Y.----PsychoGenics Inc., announces the appointment of John McCall, Ph.D., as a member of its Scientific Advisory Board, reflecting the company’s growth in the areas of Drug Discovery and Development.
August 15, 2008 - 01:06
Though his new novel is brilliant in parts, screenplay writer Dirk Wittenborn just couldn't get the chemistry right.
August 14, 2008 - 12:48
Stanley Pluly writes about the coming of age of John Keats; and Dirk Wittenborn tells a fictional account of growing up with his father, the psychopharmacologist J.R. Wittenborn.
August 14, 2008 - 09:08
In Dirk Wittenborn?s novel, an early experiment with mood-altering drugs goes awry.
August 14, 2008 - 04:51
In Dirk Wittenborn?s novel, an early experiment with mood-altering drugs goes awry.
August 12, 2008 - 21:21
(PhysOrg.com) -- Northeastern University Pharmaceutical Sciences professor and Center for Drug Discovery director Alexandros Makriyannis and a team of researchers have created a synthetic molecule that could be used to treat chronic pain in patients with diseases such as diabetes or shingles.
August 12, 2008 - 16:51
The Johns Hopkins University School of Medicine and Institute for Johns Hopkins Nursing, the Depression and Bipolar Support Alliance (DBSA), and Baylor College of Medicine, along with MJ Consulting Group, announced today the development of a curriculum-based, performance improvement initiative for better identification, diagnosis and management of people living with treatment-resistant ...
August 12, 2008 - 15:39
BALTIMORE & CHICAGO & HOUSTON----The Johns Hopkins University School of Medicine and Institute for Johns Hopkins Nursing, the Depression and Bipolar Support Alliance , and Baylor College of Medicine, along with MJ Consulting Group, announced today the development of a curriculum-based, performance improvement initiative for better identification, diagnosis and management of people living with ...
August 12, 2008 - 01:42
The tribe of Guerillas operating a Big Pharma public relations firm under cover of the Center for Public Integrity in Medicine may soon be on the path to extinction and the blogs on DrugWonks by the two out-of-control top bananas will likely be cause.